Abingdon Health (LON:ABDX) Posts Quarterly Earnings Results

Abingdon Health (LON:ABDX) announced its earnings results on Tuesday. The company reported GBX (0.51) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Abingdon Health had a negative net margin of 33.88% and a negative return on equity of 55.91%.

Abingdon Health Price Performance

Shares of ABDX traded down GBX 0.14 during mid-day trading on Thursday, hitting GBX 8.87. 46,038 shares of the company were exchanged, compared to its average volume of 234,772. The company has a debt-to-equity ratio of 15.05, a quick ratio of 1.96 and a current ratio of 1.91. The company has a 50 day moving average of GBX 10.70 and a 200-day moving average of GBX 10.53. The stock has a market cap of £22.41 million, a price-to-earnings ratio of -10.94 and a beta of 0.13. Abingdon Health has a 1-year low of GBX 5.50 and a 1-year high of GBX 13.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.